Dr. Mosli has over a decade of healthcare experience specializing in addiction, leading innovation in reorienting health systems, and increasing...
NEW YORK, Oct. 14, 2021 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) announces the availability of...
Establishes Environmental, Social & Governance CommitteeTransitions Quality & Compliance Committee to Innovation & Quality CommitteeNames Thomas J. Sullivan Senior Independent...
Signs distributors in Canada, Slovenia and United Arab Emirates; expands commercial usage at leading hospital in GermanyROSELAND, N.J., Oct. 14,...
Results published in bioRxiv Show That Delivery of Dry Powder AUG-3387 Following Viral Inoculation Led to Dose-Dependent Reduction in Lung...
RenovaCare Intellectual Property Update RenovaCare Awarded New Patents for SkinGun™: Ultra-Gentle Cell Spray Technology SCOTTSDALE, Ariz., Oct. 14, 2021 (GLOBE...
Leverages Established Track Record of Excellence in Biologics CGMP Manufacturing to Address the Rapidly Growing Cell and Gene Therapy Market...
Study Launches Phase 2A Clinical Program Designed to Explore PH94B’s Potential in Multiple Additional Anxiety Disorders Phase 2A Study in...
ATLANTA, Oct. 14, 2021 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of...
ORANGE, Calif., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Medicare Advantage company Alignment Healthcare (NASDAQ: ALHC) today announced the addition of Hoag Memorial...
WARREN, N.J., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and...
TORONTO, Ontario, Oct. 14, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Clearmind Medicine Inc. (CSE: CMND) (FSE: CWY0) (“Clearmind” or...
BOTHELL, Wash., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”), a clinical-stage biotechnology company...
-- New data in patients with POMC or LEPR deficiency obesity show setmelanotide led to clinically meaningful improvements in health...
- VRDN-001 program remains on track for key proof of concept clinical data in Thyroid Eye Disease patients in the...
Trial to evaluate new technology that may help physicians prevent heart attacks in patientsREDWOOD CITY, Calif., Oct. 14, 2021 (GLOBE...
Health Canada expands gammaCore label to include the acute and preventive treatment of migraine in adolescentsROCKAWAY, NJ, Oct. 14, 2021...
ROCKVILLE, Md., Oct. 14, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or the “Company”), a precision medicine company...
CEO Geoff Green to highlight Longeveron’s progress in Alzheimer’s disease, Aging Frailty, and Hypoplastic Left Heart Syndrome clinical research programsMIAMI,...
IRVINE, Calif., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on...
